Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Country deep-dive

Single-country regulatory or market reports. How peptides actually move through Danish customs; what the BfArM said about a specific schedule shift; the German press response to a Mounjaro shortage.

Country deep-dive

TB-500 in Sweden: import rules explained

TB-500 has no Swedish or EMA marketing authorisation and has been on the WADA Prohibited List since 2018. Here is what that means under Swedish law.

12 Sept 2026 · PeptideMethods Editorial Team · 7 min read
Country deep-dive

Tesamorelin cost in the Netherlands

Tesamorelin has no EMA authorisation after the 2012 withdrawal. No GVS listing, no official Dutch price, no ZVW cover exists. Here is the full picture for 2026.

12 Sept 2026 · PeptideMethods Editorial Team · 9 min read
Country deep-dive

What BPC-157 actually costs in the UK

BPC-157 has no UK licence, so there is no NHS price and no NICE appraisal. The only UK cost is grey-market research-chemical listings sold for research use.

10 Sept 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

Ipamorelin UK import rules for personal use

UK medicines law exempts personal imports from the manufacturer's licence rule, and that covers ipamorelin. Selling or advertising it is a separate question.

10 Sept 2026 · PeptideMethods Editorial Team · 7 min read
Country deep-dive

What CJC-1295 actually costs in the US

CJC-1295 has no FDA approval and no legal US pharmacy price. Here is why the only figures you find are grey-market, and what that low number really signals.

28 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

Ipamorelin in the US: import rules

Ipamorelin is not FDA-approved. Importing an unapproved drug for personal use is illegal under US federal law, with narrow exceptions it does not meet.

28 Jul 2026 · PeptideMethods Editorial Team · 7 min read
Country deep-dive

What ipamorelin actually costs in the US

Ipamorelin has no FDA approval and no legal US pharmacy or insurance price. The only figures are grey-market, and here is what the low number signals.

28 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

BPC-157 in the US: personal import rules

BPC-157 is not FDA-approved. Importing an unapproved drug for personal use is illegal under federal law, with narrow exceptions BPC-157 does not meet.

27 Jul 2026 · PeptideMethods Editorial Team · 7 min read
Country deep-dive

What TB-500 actually costs in the UK

TB-500 has no UK licence, so there is no NHS price and no NICE appraisal. The only UK cost is grey-market research-chemical listings sold for research use.

27 Jul 2026 · PeptideMethods Editorial Team · 7 min read
Country deep-dive

TB-500 in the UK: MHRA regulatory status

TB-500 has no MHRA marketing authorisation. Here is what UK medicines law, import rules, and WADA anti-doping status actually say.

27 Jul 2026 · PeptideMethods Editorial Team · 6 min read
Country deep-dive

Tesamorelin UK: price and NHS access

Tesamorelin has no MHRA authorisation and no NICE appraisal. No NHS route, no regulated UK price. Why the EU application was withdrawn and what it means.

27 Jul 2026 · PeptideMethods Editorial Team · 7 min read
Country deep-dive

Tesamorelin in the UK: regulatory status

Tesamorelin has no MHRA marketing authorisation. The 2012 EMA withdrawal left it unauthorised across the UK. What that means for supply, import, and athletes.

27 Jul 2026 · PeptideMethods Editorial Team · 8 min read